Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 21445275)

1.

Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development.

Kawazu M, Saso K, Tong KI, McQuire T, Goto K, Son DO, Wakeham A, Miyagishi M, Mak TW, Okada H.

PLoS One. 2011 Mar 18;6(3):e17830. doi: 10.1371/journal.pone.0017830.

2.

PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells.

Catchpole S, Spencer-Dene B, Hall D, Santangelo S, Rosewell I, Guenatri M, Beatson R, Scibetta AG, Burchell JM, Taylor-Papadimitriou J.

Int J Oncol. 2011 May;38(5):1267-77. doi: 10.3892/ijo.2011.956. Epub 2011 Feb 28.

PMID:
21369698
3.

The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth.

Yang J, Jubb AM, Pike L, Buffa FM, Turley H, Baban D, Leek R, Gatter KC, Ragoussis J, Harris AL.

Cancer Res. 2010 Aug 15;70(16):6456-66. doi: 10.1158/0008-5472.CAN-10-0413. Epub 2010 Aug 3.

4.

Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis.

Shi L, Sun L, Li Q, Liang J, Yu W, Yi X, Yang X, Li Y, Han X, Zhang Y, Xuan C, Yao Z, Shang Y.

Proc Natl Acad Sci U S A. 2011 May 3;108(18):7541-6. doi: 10.1073/pnas.1017374108. Epub 2011 Apr 18.

5.

miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.

Hui Z, Yiling C, Wenting Y, XuQun H, ChuanYi Z, Hui L.

FEBS Lett. 2015 Mar 24;589(7):812-21. doi: 10.1016/j.febslet.2015.02.014. Epub 2015 Feb 25.

PMID:
25725194
6.

The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6.

Toyokawa G, Cho HS, Iwai Y, Yoshimatsu M, Takawa M, Hayami S, Maejima K, Shimizu N, Tanaka H, Tsunoda T, Field HI, Kelly JD, Neal DE, Ponder BA, Maehara Y, Nakamura Y, Hamamoto R.

Cancer Prev Res (Phila). 2011 Dec;4(12):2051-61. doi: 10.1158/1940-6207.CAPR-11-0290. Epub 2011 Sep 19.

7.

HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb.

Ogba N, Chaplin LJ, Doughman YQ, Fujinaga K, Montano MM.

Cancer Res. 2008 Sep 1;68(17):7015-24. doi: 10.1158/0008-5472.CAN-08-0814.

8.

Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer.

Li W, Zhao L, Zang W, Liu Z, Chen L, Liu T, Xu D, Jia J.

Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):372-8. doi: 10.1016/j.bbrc.2011.11.045. Epub 2011 Nov 19.

PMID:
22133676
9.

The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells.

García-Pedrero JM, Kiskinis E, Parker MG, Belandia B.

J Biol Chem. 2006 Aug 11;281(32):22656-64. Epub 2006 Jun 12.

10.

Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.

Zhang H, Xie X, Zhu X, Zhu J, Hao C, Lu Q, Ding L, Liu Y, Zhou L, Liu Y, Huang C, Wen C, Ye Q.

J Biol Chem. 2005 Dec 30;280(52):43188-97. Epub 2005 Oct 11.

11.

HIF-1α-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanism.

Fu L, Chen L, Yang J, Ye T, Chen Y, Fang J.

Carcinogenesis. 2012 Sep;33(9):1664-73. doi: 10.1093/carcin/bgs217. Epub 2012 Jun 27.

12.

The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation.

Chand AL, Wijayakumara DD, Knower KC, Herridge KA, Howard TL, Lazarus KA, Clyne CD.

PLoS One. 2012;7(2):e31593. doi: 10.1371/journal.pone.0031593. Epub 2012 Feb 16.

13.

COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells.

Le Dily F, Métivier R, Guéguen MM, Le Péron C, Flouriot G, Tas P, Pakdel F.

Breast Cancer Res Treat. 2008 Jul;110(1):69-83. Epub 2007 Aug 3.

PMID:
17674191
14.

RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.

Thaler S, Schmidt M, Schad A, Sleeman JP.

Oncogene. 2012 Nov 22;31(47):4912-22. doi: 10.1038/onc.2011.658. Epub 2012 Jan 23.

PMID:
22266866
15.

Functional analysis of histone demethylase Jmjd2b on lipopolysaccharide-treated murine neural stem cells (NSCs).

Das ND, Choi MR, Jung KH, Park JH, Lee HT, Das A, Kim SH, Chai YG.

Neurotox Res. 2013 Feb;23(2):154-65. doi: 10.1007/s12640-012-9346-3. Epub 2012 Aug 14.

PMID:
22890720
16.
17.

Suppression of estrogen receptor-alpha transactivation by thyroid transcription factor-2 in breast cancer cells.

Park E, Gong EY, Romanelli MG, Lee K.

Biochem Biophys Res Commun. 2012 May 11;421(3):532-7. doi: 10.1016/j.bbrc.2012.04.039. Epub 2012 Apr 13.

PMID:
22521644
18.

The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium.

Rokicki J, Das PM, Giltnane JM, Wansbury O, Rimm DL, Howard BA, Jones FE.

Mol Cancer. 2010 Jun 15;9:150. doi: 10.1186/1476-4598-9-150.

19.

Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer.

Chen L, Fu L, Kong X, Xu J, Wang Z, Ma X, Akiyama Y, Chen Y, Fang J.

Br J Cancer. 2014 Feb 18;110(4):1014-26. doi: 10.1038/bjc.2013.808. Epub 2014 Jan 28.

20.

Oncogenic features of the JMJD2A histone demethylase in breast cancer.

Berry WL, Shin S, Lightfoot SA, Janknecht R.

Int J Oncol. 2012 Nov;41(5):1701-6. doi: 10.3892/ijo.2012.1618. Epub 2012 Sep 4.

PMID:
22948256
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk